Global Intracranial Drug Eluting Stents Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Intracranial Drug Eluting Stents Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 154

Published Date: 02 Jan 2024

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

According to our (Global Info Research) latest study, the global Intracranial Drug Eluting Stents market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Intracranial Drug Eluting Stents industry chain, the market status of Hospital (Cobalt-chromium Alloy Stents, Magnesium Alloy Stents), Specialty Clinic (Cobalt-chromium Alloy Stents, Magnesium Alloy Stents), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Intracranial Drug Eluting Stents.

Regionally, the report analyzes the Intracranial Drug Eluting Stents markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Intracranial Drug Eluting Stents market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Intracranial Drug Eluting Stents market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Intracranial Drug Eluting Stents industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Units), revenue generated, and market share of different by Type (e.g., Cobalt-chromium Alloy Stents, Magnesium Alloy Stents).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Intracranial Drug Eluting Stents market.

Regional Analysis: The report involves examining the Intracranial Drug Eluting Stents market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Intracranial Drug Eluting Stents market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Intracranial Drug Eluting Stents:
Company Analysis: Report covers individual Intracranial Drug Eluting Stents manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Intracranial Drug Eluting Stents This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Specialty Clinic).

Technology Analysis: Report covers specific technologies relevant to Intracranial Drug Eluting Stents. It assesses the current state, advancements, and potential future developments in Intracranial Drug Eluting Stents areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Intracranial Drug Eluting Stents market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Intracranial Drug Eluting Stents market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Cobalt-chromium Alloy Stents
Magnesium Alloy Stents
Stainless Steel Stents
Others

Market segment by Application
Hospital
Specialty Clinic
Others

Major players covered
Abbott
Medtronic Vascular
Advantec Vascular
B.Braun Melsengen
Boston Scientific
Terumo Medical
Biosensors
Biotronik
Blue Medical
DISA Vascular
Essen
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
TEDA

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intracranial Drug Eluting Stents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intracranial Drug Eluting Stents, with price, sales, revenue and global market share of Intracranial Drug Eluting Stents from 2019 to 2024.
Chapter 3, the Intracranial Drug Eluting Stents competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intracranial Drug Eluting Stents breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Intracranial Drug Eluting Stents market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intracranial Drug Eluting Stents.
Chapter 14 and 15, to describe Intracranial Drug Eluting Stents sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Intracranial Drug Eluting Stents
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Intracranial Drug Eluting Stents Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Cobalt-chromium Alloy Stents
1.3.3 Magnesium Alloy Stents
1.3.4 Stainless Steel Stents
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Intracranial Drug Eluting Stents Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Specialty Clinic
1.4.4 Others
1.5 Global Intracranial Drug Eluting Stents Market Size & Forecast
1.5.1 Global Intracranial Drug Eluting Stents Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Intracranial Drug Eluting Stents Sales Quantity (2019-2030)
1.5.3 Global Intracranial Drug Eluting Stents Average Price (2019-2030)

2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Intracranial Drug Eluting Stents Product and Services
2.1.4 Abbott Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott Recent Developments/Updates
2.2 Medtronic Vascular
2.2.1 Medtronic Vascular Details
2.2.2 Medtronic Vascular Major Business
2.2.3 Medtronic Vascular Intracranial Drug Eluting Stents Product and Services
2.2.4 Medtronic Vascular Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Medtronic Vascular Recent Developments/Updates
2.3 Advantec Vascular
2.3.1 Advantec Vascular Details
2.3.2 Advantec Vascular Major Business
2.3.3 Advantec Vascular Intracranial Drug Eluting Stents Product and Services
2.3.4 Advantec Vascular Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Advantec Vascular Recent Developments/Updates
2.4 B.Braun Melsengen
2.4.1 B.Braun Melsengen Details
2.4.2 B.Braun Melsengen Major Business
2.4.3 B.Braun Melsengen Intracranial Drug Eluting Stents Product and Services
2.4.4 B.Braun Melsengen Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 B.Braun Melsengen Recent Developments/Updates
2.5 Boston Scientific
2.5.1 Boston Scientific Details
2.5.2 Boston Scientific Major Business
2.5.3 Boston Scientific Intracranial Drug Eluting Stents Product and Services
2.5.4 Boston Scientific Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Boston Scientific Recent Developments/Updates
2.6 Terumo Medical
2.6.1 Terumo Medical Details
2.6.2 Terumo Medical Major Business
2.6.3 Terumo Medical Intracranial Drug Eluting Stents Product and Services
2.6.4 Terumo Medical Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Terumo Medical Recent Developments/Updates
2.7 Biosensors
2.7.1 Biosensors Details
2.7.2 Biosensors Major Business
2.7.3 Biosensors Intracranial Drug Eluting Stents Product and Services
2.7.4 Biosensors Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Biosensors Recent Developments/Updates
2.8 Biotronik
2.8.1 Biotronik Details
2.8.2 Biotronik Major Business
2.8.3 Biotronik Intracranial Drug Eluting Stents Product and Services
2.8.4 Biotronik Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Biotronik Recent Developments/Updates
2.9 Blue Medical
2.9.1 Blue Medical Details
2.9.2 Blue Medical Major Business
2.9.3 Blue Medical Intracranial Drug Eluting Stents Product and Services
2.9.4 Blue Medical Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Blue Medical Recent Developments/Updates
2.10 DISA Vascular
2.10.1 DISA Vascular Details
2.10.2 DISA Vascular Major Business
2.10.3 DISA Vascular Intracranial Drug Eluting Stents Product and Services
2.10.4 DISA Vascular Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 DISA Vascular Recent Developments/Updates
2.11 Essen
2.11.1 Essen Details
2.11.2 Essen Major Business
2.11.3 Essen Intracranial Drug Eluting Stents Product and Services
2.11.4 Essen Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Essen Recent Developments/Updates
2.12 MicroPort Medical
2.12.1 MicroPort Medical Details
2.12.2 MicroPort Medical Major Business
2.12.3 MicroPort Medical Intracranial Drug Eluting Stents Product and Services
2.12.4 MicroPort Medical Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 MicroPort Medical Recent Developments/Updates
2.13 MIV Therapeutics
2.13.1 MIV Therapeutics Details
2.13.2 MIV Therapeutics Major Business
2.13.3 MIV Therapeutics Intracranial Drug Eluting Stents Product and Services
2.13.4 MIV Therapeutics Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 MIV Therapeutics Recent Developments/Updates
2.14 Orbusneich
2.14.1 Orbusneich Details
2.14.2 Orbusneich Major Business
2.14.3 Orbusneich Intracranial Drug Eluting Stents Product and Services
2.14.4 Orbusneich Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Orbusneich Recent Developments/Updates
2.15 Promed Medical
2.15.1 Promed Medical Details
2.15.2 Promed Medical Major Business
2.15.3 Promed Medical Intracranial Drug Eluting Stents Product and Services
2.15.4 Promed Medical Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Promed Medical Recent Developments/Updates
2.16 Relisys Medical
2.16.1 Relisys Medical Details
2.16.2 Relisys Medical Major Business
2.16.3 Relisys Medical Intracranial Drug Eluting Stents Product and Services
2.16.4 Relisys Medical Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Relisys Medical Recent Developments/Updates
2.17 Reva Medical
2.17.1 Reva Medical Details
2.17.2 Reva Medical Major Business
2.17.3 Reva Medical Intracranial Drug Eluting Stents Product and Services
2.17.4 Reva Medical Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Reva Medical Recent Developments/Updates
2.18 Sahajanand
2.18.1 Sahajanand Details
2.18.2 Sahajanand Major Business
2.18.3 Sahajanand Intracranial Drug Eluting Stents Product and Services
2.18.4 Sahajanand Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Sahajanand Recent Developments/Updates
2.19 Sino Medical
2.19.1 Sino Medical Details
2.19.2 Sino Medical Major Business
2.19.3 Sino Medical Intracranial Drug Eluting Stents Product and Services
2.19.4 Sino Medical Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Sino Medical Recent Developments/Updates
2.20 Sorin
2.20.1 Sorin Details
2.20.2 Sorin Major Business
2.20.3 Sorin Intracranial Drug Eluting Stents Product and Services
2.20.4 Sorin Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Sorin Recent Developments/Updates
2.21 TEDA
2.21.1 TEDA Details
2.21.2 TEDA Major Business
2.21.3 TEDA Intracranial Drug Eluting Stents Product and Services
2.21.4 TEDA Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 TEDA Recent Developments/Updates

3 Competitive Environment: Intracranial Drug Eluting Stents by Manufacturer
3.1 Global Intracranial Drug Eluting Stents Sales Quantity by Manufacturer (2019-2024)
3.2 Global Intracranial Drug Eluting Stents Revenue by Manufacturer (2019-2024)
3.3 Global Intracranial Drug Eluting Stents Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Intracranial Drug Eluting Stents by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Intracranial Drug Eluting Stents Manufacturer Market Share in 2023
3.4.2 Top 6 Intracranial Drug Eluting Stents Manufacturer Market Share in 2023
3.5 Intracranial Drug Eluting Stents Market: Overall Company Footprint Analysis
3.5.1 Intracranial Drug Eluting Stents Market: Region Footprint
3.5.2 Intracranial Drug Eluting Stents Market: Company Product Type Footprint
3.5.3 Intracranial Drug Eluting Stents Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Intracranial Drug Eluting Stents Market Size by Region
4.1.1 Global Intracranial Drug Eluting Stents Sales Quantity by Region (2019-2030)
4.1.2 Global Intracranial Drug Eluting Stents Consumption Value by Region (2019-2030)
4.1.3 Global Intracranial Drug Eluting Stents Average Price by Region (2019-2030)
4.2 North America Intracranial Drug Eluting Stents Consumption Value (2019-2030)
4.3 Europe Intracranial Drug Eluting Stents Consumption Value (2019-2030)
4.4 Asia-Pacific Intracranial Drug Eluting Stents Consumption Value (2019-2030)
4.5 South America Intracranial Drug Eluting Stents Consumption Value (2019-2030)
4.6 Middle East and Africa Intracranial Drug Eluting Stents Consumption Value (2019-2030)

5 Market Segment by Type
5.1 Global Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2030)
5.2 Global Intracranial Drug Eluting Stents Consumption Value by Type (2019-2030)
5.3 Global Intracranial Drug Eluting Stents Average Price by Type (2019-2030)

6 Market Segment by Application
6.1 Global Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2030)
6.2 Global Intracranial Drug Eluting Stents Consumption Value by Application (2019-2030)
6.3 Global Intracranial Drug Eluting Stents Average Price by Application (2019-2030)

7 North America
7.1 North America Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2030)
7.2 North America Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2030)
7.3 North America Intracranial Drug Eluting Stents Market Size by Country
7.3.1 North America Intracranial Drug Eluting Stents Sales Quantity by Country (2019-2030)
7.3.2 North America Intracranial Drug Eluting Stents Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
8.1 Europe Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2030)
8.2 Europe Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2030)
8.3 Europe Intracranial Drug Eluting Stents Market Size by Country
8.3.1 Europe Intracranial Drug Eluting Stents Sales Quantity by Country (2019-2030)
8.3.2 Europe Intracranial Drug Eluting Stents Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
9.1 Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Intracranial Drug Eluting Stents Market Size by Region
9.3.1 Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Intracranial Drug Eluting Stents Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
10.1 South America Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2030)
10.2 South America Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2030)
10.3 South America Intracranial Drug Eluting Stents Market Size by Country
10.3.1 South America Intracranial Drug Eluting Stents Sales Quantity by Country (2019-2030)
10.3.2 South America Intracranial Drug Eluting Stents Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
11.1 Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Intracranial Drug Eluting Stents Market Size by Country
11.3.1 Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Intracranial Drug Eluting Stents Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
12.1 Intracranial Drug Eluting Stents Market Drivers
12.2 Intracranial Drug Eluting Stents Market Restraints
12.3 Intracranial Drug Eluting Stents Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
13.1 Raw Material of Intracranial Drug Eluting Stents and Key Manufacturers
13.2 Manufacturing Costs Percentage of Intracranial Drug Eluting Stents
13.3 Intracranial Drug Eluting Stents Production Process
13.4 Intracranial Drug Eluting Stents Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Intracranial Drug Eluting Stents Typical Distributors
14.3 Intracranial Drug Eluting Stents Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Intracranial Drug Eluting Stents Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Intracranial Drug Eluting Stents Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Intracranial Drug Eluting Stents Product and Services
Table 6. Abbott Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Abbott Recent Developments/Updates
Table 8. Medtronic Vascular Basic Information, Manufacturing Base and Competitors
Table 9. Medtronic Vascular Major Business
Table 10. Medtronic Vascular Intracranial Drug Eluting Stents Product and Services
Table 11. Medtronic Vascular Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Medtronic Vascular Recent Developments/Updates
Table 13. Advantec Vascular Basic Information, Manufacturing Base and Competitors
Table 14. Advantec Vascular Major Business
Table 15. Advantec Vascular Intracranial Drug Eluting Stents Product and Services
Table 16. Advantec Vascular Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Advantec Vascular Recent Developments/Updates
Table 18. B.Braun Melsengen Basic Information, Manufacturing Base and Competitors
Table 19. B.Braun Melsengen Major Business
Table 20. B.Braun Melsengen Intracranial Drug Eluting Stents Product and Services
Table 21. B.Braun Melsengen Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. B.Braun Melsengen Recent Developments/Updates
Table 23. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 24. Boston Scientific Major Business
Table 25. Boston Scientific Intracranial Drug Eluting Stents Product and Services
Table 26. Boston Scientific Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Boston Scientific Recent Developments/Updates
Table 28. Terumo Medical Basic Information, Manufacturing Base and Competitors
Table 29. Terumo Medical Major Business
Table 30. Terumo Medical Intracranial Drug Eluting Stents Product and Services
Table 31. Terumo Medical Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Terumo Medical Recent Developments/Updates
Table 33. Biosensors Basic Information, Manufacturing Base and Competitors
Table 34. Biosensors Major Business
Table 35. Biosensors Intracranial Drug Eluting Stents Product and Services
Table 36. Biosensors Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Biosensors Recent Developments/Updates
Table 38. Biotronik Basic Information, Manufacturing Base and Competitors
Table 39. Biotronik Major Business
Table 40. Biotronik Intracranial Drug Eluting Stents Product and Services
Table 41. Biotronik Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Biotronik Recent Developments/Updates
Table 43. Blue Medical Basic Information, Manufacturing Base and Competitors
Table 44. Blue Medical Major Business
Table 45. Blue Medical Intracranial Drug Eluting Stents Product and Services
Table 46. Blue Medical Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Blue Medical Recent Developments/Updates
Table 48. DISA Vascular Basic Information, Manufacturing Base and Competitors
Table 49. DISA Vascular Major Business
Table 50. DISA Vascular Intracranial Drug Eluting Stents Product and Services
Table 51. DISA Vascular Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. DISA Vascular Recent Developments/Updates
Table 53. Essen Basic Information, Manufacturing Base and Competitors
Table 54. Essen Major Business
Table 55. Essen Intracranial Drug Eluting Stents Product and Services
Table 56. Essen Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Essen Recent Developments/Updates
Table 58. MicroPort Medical Basic Information, Manufacturing Base and Competitors
Table 59. MicroPort Medical Major Business
Table 60. MicroPort Medical Intracranial Drug Eluting Stents Product and Services
Table 61. MicroPort Medical Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. MicroPort Medical Recent Developments/Updates
Table 63. MIV Therapeutics Basic Information, Manufacturing Base and Competitors
Table 64. MIV Therapeutics Major Business
Table 65. MIV Therapeutics Intracranial Drug Eluting Stents Product and Services
Table 66. MIV Therapeutics Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. MIV Therapeutics Recent Developments/Updates
Table 68. Orbusneich Basic Information, Manufacturing Base and Competitors
Table 69. Orbusneich Major Business
Table 70. Orbusneich Intracranial Drug Eluting Stents Product and Services
Table 71. Orbusneich Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Orbusneich Recent Developments/Updates
Table 73. Promed Medical Basic Information, Manufacturing Base and Competitors
Table 74. Promed Medical Major Business
Table 75. Promed Medical Intracranial Drug Eluting Stents Product and Services
Table 76. Promed Medical Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Promed Medical Recent Developments/Updates
Table 78. Relisys Medical Basic Information, Manufacturing Base and Competitors
Table 79. Relisys Medical Major Business
Table 80. Relisys Medical Intracranial Drug Eluting Stents Product and Services
Table 81. Relisys Medical Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Relisys Medical Recent Developments/Updates
Table 83. Reva Medical Basic Information, Manufacturing Base and Competitors
Table 84. Reva Medical Major Business
Table 85. Reva Medical Intracranial Drug Eluting Stents Product and Services
Table 86. Reva Medical Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Reva Medical Recent Developments/Updates
Table 88. Sahajanand Basic Information, Manufacturing Base and Competitors
Table 89. Sahajanand Major Business
Table 90. Sahajanand Intracranial Drug Eluting Stents Product and Services
Table 91. Sahajanand Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Sahajanand Recent Developments/Updates
Table 93. Sino Medical Basic Information, Manufacturing Base and Competitors
Table 94. Sino Medical Major Business
Table 95. Sino Medical Intracranial Drug Eluting Stents Product and Services
Table 96. Sino Medical Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Sino Medical Recent Developments/Updates
Table 98. Sorin Basic Information, Manufacturing Base and Competitors
Table 99. Sorin Major Business
Table 100. Sorin Intracranial Drug Eluting Stents Product and Services
Table 101. Sorin Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Sorin Recent Developments/Updates
Table 103. TEDA Basic Information, Manufacturing Base and Competitors
Table 104. TEDA Major Business
Table 105. TEDA Intracranial Drug Eluting Stents Product and Services
Table 106. TEDA Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. TEDA Recent Developments/Updates
Table 108. Global Intracranial Drug Eluting Stents Sales Quantity by Manufacturer (2019-2024) & (Units)
Table 109. Global Intracranial Drug Eluting Stents Revenue by Manufacturer (2019-2024) & (USD Million)
Table 110. Global Intracranial Drug Eluting Stents Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 111. Market Position of Manufacturers in Intracranial Drug Eluting Stents, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 112. Head Office and Intracranial Drug Eluting Stents Production Site of Key Manufacturer
Table 113. Intracranial Drug Eluting Stents Market: Company Product Type Footprint
Table 114. Intracranial Drug Eluting Stents Market: Company Product Application Footprint
Table 115. Intracranial Drug Eluting Stents New Market Entrants and Barriers to Market Entry
Table 116. Intracranial Drug Eluting Stents Mergers, Acquisition, Agreements, and Collaborations
Table 117. Global Intracranial Drug Eluting Stents Sales Quantity by Region (2019-2024) & (Units)
Table 118. Global Intracranial Drug Eluting Stents Sales Quantity by Region (2025-2030) & (Units)
Table 119. Global Intracranial Drug Eluting Stents Consumption Value by Region (2019-2024) & (USD Million)
Table 120. Global Intracranial Drug Eluting Stents Consumption Value by Region (2025-2030) & (USD Million)
Table 121. Global Intracranial Drug Eluting Stents Average Price by Region (2019-2024) & (US$/Unit)
Table 122. Global Intracranial Drug Eluting Stents Average Price by Region (2025-2030) & (US$/Unit)
Table 123. Global Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2024) & (Units)
Table 124. Global Intracranial Drug Eluting Stents Sales Quantity by Type (2025-2030) & (Units)
Table 125. Global Intracranial Drug Eluting Stents Consumption Value by Type (2019-2024) & (USD Million)
Table 126. Global Intracranial Drug Eluting Stents Consumption Value by Type (2025-2030) & (USD Million)
Table 127. Global Intracranial Drug Eluting Stents Average Price by Type (2019-2024) & (US$/Unit)
Table 128. Global Intracranial Drug Eluting Stents Average Price by Type (2025-2030) & (US$/Unit)
Table 129. Global Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2024) & (Units)
Table 130. Global Intracranial Drug Eluting Stents Sales Quantity by Application (2025-2030) & (Units)
Table 131. Global Intracranial Drug Eluting Stents Consumption Value by Application (2019-2024) & (USD Million)
Table 132. Global Intracranial Drug Eluting Stents Consumption Value by Application (2025-2030) & (USD Million)
Table 133. Global Intracranial Drug Eluting Stents Average Price by Application (2019-2024) & (US$/Unit)
Table 134. Global Intracranial Drug Eluting Stents Average Price by Application (2025-2030) & (US$/Unit)
Table 135. North America Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2024) & (Units)
Table 136. North America Intracranial Drug Eluting Stents Sales Quantity by Type (2025-2030) & (Units)
Table 137. North America Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2024) & (Units)
Table 138. North America Intracranial Drug Eluting Stents Sales Quantity by Application (2025-2030) & (Units)
Table 139. North America Intracranial Drug Eluting Stents Sales Quantity by Country (2019-2024) & (Units)
Table 140. North America Intracranial Drug Eluting Stents Sales Quantity by Country (2025-2030) & (Units)
Table 141. North America Intracranial Drug Eluting Stents Consumption Value by Country (2019-2024) & (USD Million)
Table 142. North America Intracranial Drug Eluting Stents Consumption Value by Country (2025-2030) & (USD Million)
Table 143. Europe Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2024) & (Units)
Table 144. Europe Intracranial Drug Eluting Stents Sales Quantity by Type (2025-2030) & (Units)
Table 145. Europe Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2024) & (Units)
Table 146. Europe Intracranial Drug Eluting Stents Sales Quantity by Application (2025-2030) & (Units)
Table 147. Europe Intracranial Drug Eluting Stents Sales Quantity by Country (2019-2024) & (Units)
Table 148. Europe Intracranial Drug Eluting Stents Sales Quantity by Country (2025-2030) & (Units)
Table 149. Europe Intracranial Drug Eluting Stents Consumption Value by Country (2019-2024) & (USD Million)
Table 150. Europe Intracranial Drug Eluting Stents Consumption Value by Country (2025-2030) & (USD Million)
Table 151. Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2024) & (Units)
Table 152. Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity by Type (2025-2030) & (Units)
Table 153. Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2024) & (Units)
Table 154. Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity by Application (2025-2030) & (Units)
Table 155. Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity by Region (2019-2024) & (Units)
Table 156. Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity by Region (2025-2030) & (Units)
Table 157. Asia-Pacific Intracranial Drug Eluting Stents Consumption Value by Region (2019-2024) & (USD Million)
Table 158. Asia-Pacific Intracranial Drug Eluting Stents Consumption Value by Region (2025-2030) & (USD Million)
Table 159. South America Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2024) & (Units)
Table 160. South America Intracranial Drug Eluting Stents Sales Quantity by Type (2025-2030) & (Units)
Table 161. South America Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2024) & (Units)
Table 162. South America Intracranial Drug Eluting Stents Sales Quantity by Application (2025-2030) & (Units)
Table 163. South America Intracranial Drug Eluting Stents Sales Quantity by Country (2019-2024) & (Units)
Table 164. South America Intracranial Drug Eluting Stents Sales Quantity by Country (2025-2030) & (Units)
Table 165. South America Intracranial Drug Eluting Stents Consumption Value by Country (2019-2024) & (USD Million)
Table 166. South America Intracranial Drug Eluting Stents Consumption Value by Country (2025-2030) & (USD Million)
Table 167. Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2024) & (Units)
Table 168. Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity by Type (2025-2030) & (Units)
Table 169. Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2024) & (Units)
Table 170. Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity by Application (2025-2030) & (Units)
Table 171. Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity by Region (2019-2024) & (Units)
Table 172. Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity by Region (2025-2030) & (Units)
Table 173. Middle East & Africa Intracranial Drug Eluting Stents Consumption Value by Region (2019-2024) & (USD Million)
Table 174. Middle East & Africa Intracranial Drug Eluting Stents Consumption Value by Region (2025-2030) & (USD Million)
Table 175. Intracranial Drug Eluting Stents Raw Material
Table 176. Key Manufacturers of Intracranial Drug Eluting Stents Raw Materials
Table 177. Intracranial Drug Eluting Stents Typical Distributors
Table 178. Intracranial Drug Eluting Stents Typical Customers
List of Figures
Figure 1. Intracranial Drug Eluting Stents Picture
Figure 2. Global Intracranial Drug Eluting Stents Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Intracranial Drug Eluting Stents Consumption Value Market Share by Type in 2023
Figure 4. Cobalt-chromium Alloy Stents Examples
Figure 5. Magnesium Alloy Stents Examples
Figure 6. Stainless Steel Stents Examples
Figure 7. Others Examples
Figure 8. Global Intracranial Drug Eluting Stents Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Intracranial Drug Eluting Stents Consumption Value Market Share by Application in 2023
Figure 10. Hospital Examples
Figure 11. Specialty Clinic Examples
Figure 12. Others Examples
Figure 13. Global Intracranial Drug Eluting Stents Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Intracranial Drug Eluting Stents Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Intracranial Drug Eluting Stents Sales Quantity (2019-2030) & (Units)
Figure 16. Global Intracranial Drug Eluting Stents Average Price (2019-2030) & (US$/Unit)
Figure 17. Global Intracranial Drug Eluting Stents Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Intracranial Drug Eluting Stents Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Intracranial Drug Eluting Stents by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Intracranial Drug Eluting Stents Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Intracranial Drug Eluting Stents Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Intracranial Drug Eluting Stents Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Intracranial Drug Eluting Stents Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Intracranial Drug Eluting Stents Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Intracranial Drug Eluting Stents Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Intracranial Drug Eluting Stents Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Intracranial Drug Eluting Stents Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Intracranial Drug Eluting Stents Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Intracranial Drug Eluting Stents Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Intracranial Drug Eluting Stents Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Intracranial Drug Eluting Stents Average Price by Type (2019-2030) & (US$/Unit)
Figure 32. Global Intracranial Drug Eluting Stents Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Intracranial Drug Eluting Stents Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Intracranial Drug Eluting Stents Average Price by Application (2019-2030) & (US$/Unit)
Figure 35. North America Intracranial Drug Eluting Stents Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Intracranial Drug Eluting Stents Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Intracranial Drug Eluting Stents Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Intracranial Drug Eluting Stents Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Intracranial Drug Eluting Stents Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Intracranial Drug Eluting Stents Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Intracranial Drug Eluting Stents Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Intracranial Drug Eluting Stents Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Intracranial Drug Eluting Stents Consumption Value Market Share by Region (2019-2030)
Figure 55. China Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Intracranial Drug Eluting Stents Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Intracranial Drug Eluting Stents Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Intracranial Drug Eluting Stents Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Intracranial Drug Eluting Stents Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Intracranial Drug Eluting Stents Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Intracranial Drug Eluting Stents Market Drivers
Figure 76. Intracranial Drug Eluting Stents Market Restraints
Figure 77. Intracranial Drug Eluting Stents Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Intracranial Drug Eluting Stents in 2023
Figure 80. Manufacturing Process Analysis of Intracranial Drug Eluting Stents
Figure 81. Intracranial Drug Eluting Stents Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Abbott
Medtronic Vascular
Advantec Vascular
B.Braun Melsengen
Boston Scientific
Terumo Medical
Biosensors
Biotronik
Blue Medical
DISA Vascular
Essen
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
TEDA
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Intracranial Drug Eluting Stents Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Intracranial Drug Eluting Stents Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 154

Published Date: 02 Jan 2024

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

According to our (Global Info Research) latest study, the global Intracranial Drug Eluting Stents market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Intracranial Drug Eluting Stents industry chain, the market status of Hospital (Cobalt-chromium Alloy Stents, Magnesium Alloy Stents), Specialty Clinic (Cobalt-chromium Alloy Stents, Magnesium Alloy Stents), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Intracranial Drug Eluting Stents.

Regionally, the report analyzes the Intracranial Drug Eluting Stents markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Intracranial Drug Eluting Stents market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Intracranial Drug Eluting Stents market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Intracranial Drug Eluting Stents industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Units), revenue generated, and market share of different by Type (e.g., Cobalt-chromium Alloy Stents, Magnesium Alloy Stents).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Intracranial Drug Eluting Stents market.

Regional Analysis: The report involves examining the Intracranial Drug Eluting Stents market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Intracranial Drug Eluting Stents market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Intracranial Drug Eluting Stents:
Company Analysis: Report covers individual Intracranial Drug Eluting Stents manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Intracranial Drug Eluting Stents This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Specialty Clinic).

Technology Analysis: Report covers specific technologies relevant to Intracranial Drug Eluting Stents. It assesses the current state, advancements, and potential future developments in Intracranial Drug Eluting Stents areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Intracranial Drug Eluting Stents market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Intracranial Drug Eluting Stents market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Cobalt-chromium Alloy Stents
Magnesium Alloy Stents
Stainless Steel Stents
Others

Market segment by Application
Hospital
Specialty Clinic
Others

Major players covered
Abbott
Medtronic Vascular
Advantec Vascular
B.Braun Melsengen
Boston Scientific
Terumo Medical
Biosensors
Biotronik
Blue Medical
DISA Vascular
Essen
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
TEDA

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intracranial Drug Eluting Stents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intracranial Drug Eluting Stents, with price, sales, revenue and global market share of Intracranial Drug Eluting Stents from 2019 to 2024.
Chapter 3, the Intracranial Drug Eluting Stents competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intracranial Drug Eluting Stents breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Intracranial Drug Eluting Stents market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intracranial Drug Eluting Stents.
Chapter 14 and 15, to describe Intracranial Drug Eluting Stents sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Intracranial Drug Eluting Stents
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Intracranial Drug Eluting Stents Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Cobalt-chromium Alloy Stents
1.3.3 Magnesium Alloy Stents
1.3.4 Stainless Steel Stents
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Intracranial Drug Eluting Stents Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Specialty Clinic
1.4.4 Others
1.5 Global Intracranial Drug Eluting Stents Market Size & Forecast
1.5.1 Global Intracranial Drug Eluting Stents Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Intracranial Drug Eluting Stents Sales Quantity (2019-2030)
1.5.3 Global Intracranial Drug Eluting Stents Average Price (2019-2030)

2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Intracranial Drug Eluting Stents Product and Services
2.1.4 Abbott Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott Recent Developments/Updates
2.2 Medtronic Vascular
2.2.1 Medtronic Vascular Details
2.2.2 Medtronic Vascular Major Business
2.2.3 Medtronic Vascular Intracranial Drug Eluting Stents Product and Services
2.2.4 Medtronic Vascular Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Medtronic Vascular Recent Developments/Updates
2.3 Advantec Vascular
2.3.1 Advantec Vascular Details
2.3.2 Advantec Vascular Major Business
2.3.3 Advantec Vascular Intracranial Drug Eluting Stents Product and Services
2.3.4 Advantec Vascular Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Advantec Vascular Recent Developments/Updates
2.4 B.Braun Melsengen
2.4.1 B.Braun Melsengen Details
2.4.2 B.Braun Melsengen Major Business
2.4.3 B.Braun Melsengen Intracranial Drug Eluting Stents Product and Services
2.4.4 B.Braun Melsengen Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 B.Braun Melsengen Recent Developments/Updates
2.5 Boston Scientific
2.5.1 Boston Scientific Details
2.5.2 Boston Scientific Major Business
2.5.3 Boston Scientific Intracranial Drug Eluting Stents Product and Services
2.5.4 Boston Scientific Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Boston Scientific Recent Developments/Updates
2.6 Terumo Medical
2.6.1 Terumo Medical Details
2.6.2 Terumo Medical Major Business
2.6.3 Terumo Medical Intracranial Drug Eluting Stents Product and Services
2.6.4 Terumo Medical Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Terumo Medical Recent Developments/Updates
2.7 Biosensors
2.7.1 Biosensors Details
2.7.2 Biosensors Major Business
2.7.3 Biosensors Intracranial Drug Eluting Stents Product and Services
2.7.4 Biosensors Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Biosensors Recent Developments/Updates
2.8 Biotronik
2.8.1 Biotronik Details
2.8.2 Biotronik Major Business
2.8.3 Biotronik Intracranial Drug Eluting Stents Product and Services
2.8.4 Biotronik Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Biotronik Recent Developments/Updates
2.9 Blue Medical
2.9.1 Blue Medical Details
2.9.2 Blue Medical Major Business
2.9.3 Blue Medical Intracranial Drug Eluting Stents Product and Services
2.9.4 Blue Medical Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Blue Medical Recent Developments/Updates
2.10 DISA Vascular
2.10.1 DISA Vascular Details
2.10.2 DISA Vascular Major Business
2.10.3 DISA Vascular Intracranial Drug Eluting Stents Product and Services
2.10.4 DISA Vascular Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 DISA Vascular Recent Developments/Updates
2.11 Essen
2.11.1 Essen Details
2.11.2 Essen Major Business
2.11.3 Essen Intracranial Drug Eluting Stents Product and Services
2.11.4 Essen Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Essen Recent Developments/Updates
2.12 MicroPort Medical
2.12.1 MicroPort Medical Details
2.12.2 MicroPort Medical Major Business
2.12.3 MicroPort Medical Intracranial Drug Eluting Stents Product and Services
2.12.4 MicroPort Medical Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 MicroPort Medical Recent Developments/Updates
2.13 MIV Therapeutics
2.13.1 MIV Therapeutics Details
2.13.2 MIV Therapeutics Major Business
2.13.3 MIV Therapeutics Intracranial Drug Eluting Stents Product and Services
2.13.4 MIV Therapeutics Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 MIV Therapeutics Recent Developments/Updates
2.14 Orbusneich
2.14.1 Orbusneich Details
2.14.2 Orbusneich Major Business
2.14.3 Orbusneich Intracranial Drug Eluting Stents Product and Services
2.14.4 Orbusneich Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Orbusneich Recent Developments/Updates
2.15 Promed Medical
2.15.1 Promed Medical Details
2.15.2 Promed Medical Major Business
2.15.3 Promed Medical Intracranial Drug Eluting Stents Product and Services
2.15.4 Promed Medical Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Promed Medical Recent Developments/Updates
2.16 Relisys Medical
2.16.1 Relisys Medical Details
2.16.2 Relisys Medical Major Business
2.16.3 Relisys Medical Intracranial Drug Eluting Stents Product and Services
2.16.4 Relisys Medical Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Relisys Medical Recent Developments/Updates
2.17 Reva Medical
2.17.1 Reva Medical Details
2.17.2 Reva Medical Major Business
2.17.3 Reva Medical Intracranial Drug Eluting Stents Product and Services
2.17.4 Reva Medical Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Reva Medical Recent Developments/Updates
2.18 Sahajanand
2.18.1 Sahajanand Details
2.18.2 Sahajanand Major Business
2.18.3 Sahajanand Intracranial Drug Eluting Stents Product and Services
2.18.4 Sahajanand Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Sahajanand Recent Developments/Updates
2.19 Sino Medical
2.19.1 Sino Medical Details
2.19.2 Sino Medical Major Business
2.19.3 Sino Medical Intracranial Drug Eluting Stents Product and Services
2.19.4 Sino Medical Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Sino Medical Recent Developments/Updates
2.20 Sorin
2.20.1 Sorin Details
2.20.2 Sorin Major Business
2.20.3 Sorin Intracranial Drug Eluting Stents Product and Services
2.20.4 Sorin Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Sorin Recent Developments/Updates
2.21 TEDA
2.21.1 TEDA Details
2.21.2 TEDA Major Business
2.21.3 TEDA Intracranial Drug Eluting Stents Product and Services
2.21.4 TEDA Intracranial Drug Eluting Stents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 TEDA Recent Developments/Updates

3 Competitive Environment: Intracranial Drug Eluting Stents by Manufacturer
3.1 Global Intracranial Drug Eluting Stents Sales Quantity by Manufacturer (2019-2024)
3.2 Global Intracranial Drug Eluting Stents Revenue by Manufacturer (2019-2024)
3.3 Global Intracranial Drug Eluting Stents Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Intracranial Drug Eluting Stents by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Intracranial Drug Eluting Stents Manufacturer Market Share in 2023
3.4.2 Top 6 Intracranial Drug Eluting Stents Manufacturer Market Share in 2023
3.5 Intracranial Drug Eluting Stents Market: Overall Company Footprint Analysis
3.5.1 Intracranial Drug Eluting Stents Market: Region Footprint
3.5.2 Intracranial Drug Eluting Stents Market: Company Product Type Footprint
3.5.3 Intracranial Drug Eluting Stents Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Intracranial Drug Eluting Stents Market Size by Region
4.1.1 Global Intracranial Drug Eluting Stents Sales Quantity by Region (2019-2030)
4.1.2 Global Intracranial Drug Eluting Stents Consumption Value by Region (2019-2030)
4.1.3 Global Intracranial Drug Eluting Stents Average Price by Region (2019-2030)
4.2 North America Intracranial Drug Eluting Stents Consumption Value (2019-2030)
4.3 Europe Intracranial Drug Eluting Stents Consumption Value (2019-2030)
4.4 Asia-Pacific Intracranial Drug Eluting Stents Consumption Value (2019-2030)
4.5 South America Intracranial Drug Eluting Stents Consumption Value (2019-2030)
4.6 Middle East and Africa Intracranial Drug Eluting Stents Consumption Value (2019-2030)

5 Market Segment by Type
5.1 Global Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2030)
5.2 Global Intracranial Drug Eluting Stents Consumption Value by Type (2019-2030)
5.3 Global Intracranial Drug Eluting Stents Average Price by Type (2019-2030)

6 Market Segment by Application
6.1 Global Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2030)
6.2 Global Intracranial Drug Eluting Stents Consumption Value by Application (2019-2030)
6.3 Global Intracranial Drug Eluting Stents Average Price by Application (2019-2030)

7 North America
7.1 North America Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2030)
7.2 North America Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2030)
7.3 North America Intracranial Drug Eluting Stents Market Size by Country
7.3.1 North America Intracranial Drug Eluting Stents Sales Quantity by Country (2019-2030)
7.3.2 North America Intracranial Drug Eluting Stents Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
8.1 Europe Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2030)
8.2 Europe Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2030)
8.3 Europe Intracranial Drug Eluting Stents Market Size by Country
8.3.1 Europe Intracranial Drug Eluting Stents Sales Quantity by Country (2019-2030)
8.3.2 Europe Intracranial Drug Eluting Stents Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
9.1 Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Intracranial Drug Eluting Stents Market Size by Region
9.3.1 Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Intracranial Drug Eluting Stents Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
10.1 South America Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2030)
10.2 South America Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2030)
10.3 South America Intracranial Drug Eluting Stents Market Size by Country
10.3.1 South America Intracranial Drug Eluting Stents Sales Quantity by Country (2019-2030)
10.3.2 South America Intracranial Drug Eluting Stents Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
11.1 Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Intracranial Drug Eluting Stents Market Size by Country
11.3.1 Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Intracranial Drug Eluting Stents Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
12.1 Intracranial Drug Eluting Stents Market Drivers
12.2 Intracranial Drug Eluting Stents Market Restraints
12.3 Intracranial Drug Eluting Stents Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
13.1 Raw Material of Intracranial Drug Eluting Stents and Key Manufacturers
13.2 Manufacturing Costs Percentage of Intracranial Drug Eluting Stents
13.3 Intracranial Drug Eluting Stents Production Process
13.4 Intracranial Drug Eluting Stents Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Intracranial Drug Eluting Stents Typical Distributors
14.3 Intracranial Drug Eluting Stents Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Intracranial Drug Eluting Stents Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Intracranial Drug Eluting Stents Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Intracranial Drug Eluting Stents Product and Services
Table 6. Abbott Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Abbott Recent Developments/Updates
Table 8. Medtronic Vascular Basic Information, Manufacturing Base and Competitors
Table 9. Medtronic Vascular Major Business
Table 10. Medtronic Vascular Intracranial Drug Eluting Stents Product and Services
Table 11. Medtronic Vascular Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Medtronic Vascular Recent Developments/Updates
Table 13. Advantec Vascular Basic Information, Manufacturing Base and Competitors
Table 14. Advantec Vascular Major Business
Table 15. Advantec Vascular Intracranial Drug Eluting Stents Product and Services
Table 16. Advantec Vascular Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Advantec Vascular Recent Developments/Updates
Table 18. B.Braun Melsengen Basic Information, Manufacturing Base and Competitors
Table 19. B.Braun Melsengen Major Business
Table 20. B.Braun Melsengen Intracranial Drug Eluting Stents Product and Services
Table 21. B.Braun Melsengen Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. B.Braun Melsengen Recent Developments/Updates
Table 23. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 24. Boston Scientific Major Business
Table 25. Boston Scientific Intracranial Drug Eluting Stents Product and Services
Table 26. Boston Scientific Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Boston Scientific Recent Developments/Updates
Table 28. Terumo Medical Basic Information, Manufacturing Base and Competitors
Table 29. Terumo Medical Major Business
Table 30. Terumo Medical Intracranial Drug Eluting Stents Product and Services
Table 31. Terumo Medical Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Terumo Medical Recent Developments/Updates
Table 33. Biosensors Basic Information, Manufacturing Base and Competitors
Table 34. Biosensors Major Business
Table 35. Biosensors Intracranial Drug Eluting Stents Product and Services
Table 36. Biosensors Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Biosensors Recent Developments/Updates
Table 38. Biotronik Basic Information, Manufacturing Base and Competitors
Table 39. Biotronik Major Business
Table 40. Biotronik Intracranial Drug Eluting Stents Product and Services
Table 41. Biotronik Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Biotronik Recent Developments/Updates
Table 43. Blue Medical Basic Information, Manufacturing Base and Competitors
Table 44. Blue Medical Major Business
Table 45. Blue Medical Intracranial Drug Eluting Stents Product and Services
Table 46. Blue Medical Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Blue Medical Recent Developments/Updates
Table 48. DISA Vascular Basic Information, Manufacturing Base and Competitors
Table 49. DISA Vascular Major Business
Table 50. DISA Vascular Intracranial Drug Eluting Stents Product and Services
Table 51. DISA Vascular Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. DISA Vascular Recent Developments/Updates
Table 53. Essen Basic Information, Manufacturing Base and Competitors
Table 54. Essen Major Business
Table 55. Essen Intracranial Drug Eluting Stents Product and Services
Table 56. Essen Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Essen Recent Developments/Updates
Table 58. MicroPort Medical Basic Information, Manufacturing Base and Competitors
Table 59. MicroPort Medical Major Business
Table 60. MicroPort Medical Intracranial Drug Eluting Stents Product and Services
Table 61. MicroPort Medical Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. MicroPort Medical Recent Developments/Updates
Table 63. MIV Therapeutics Basic Information, Manufacturing Base and Competitors
Table 64. MIV Therapeutics Major Business
Table 65. MIV Therapeutics Intracranial Drug Eluting Stents Product and Services
Table 66. MIV Therapeutics Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. MIV Therapeutics Recent Developments/Updates
Table 68. Orbusneich Basic Information, Manufacturing Base and Competitors
Table 69. Orbusneich Major Business
Table 70. Orbusneich Intracranial Drug Eluting Stents Product and Services
Table 71. Orbusneich Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Orbusneich Recent Developments/Updates
Table 73. Promed Medical Basic Information, Manufacturing Base and Competitors
Table 74. Promed Medical Major Business
Table 75. Promed Medical Intracranial Drug Eluting Stents Product and Services
Table 76. Promed Medical Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Promed Medical Recent Developments/Updates
Table 78. Relisys Medical Basic Information, Manufacturing Base and Competitors
Table 79. Relisys Medical Major Business
Table 80. Relisys Medical Intracranial Drug Eluting Stents Product and Services
Table 81. Relisys Medical Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Relisys Medical Recent Developments/Updates
Table 83. Reva Medical Basic Information, Manufacturing Base and Competitors
Table 84. Reva Medical Major Business
Table 85. Reva Medical Intracranial Drug Eluting Stents Product and Services
Table 86. Reva Medical Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Reva Medical Recent Developments/Updates
Table 88. Sahajanand Basic Information, Manufacturing Base and Competitors
Table 89. Sahajanand Major Business
Table 90. Sahajanand Intracranial Drug Eluting Stents Product and Services
Table 91. Sahajanand Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Sahajanand Recent Developments/Updates
Table 93. Sino Medical Basic Information, Manufacturing Base and Competitors
Table 94. Sino Medical Major Business
Table 95. Sino Medical Intracranial Drug Eluting Stents Product and Services
Table 96. Sino Medical Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Sino Medical Recent Developments/Updates
Table 98. Sorin Basic Information, Manufacturing Base and Competitors
Table 99. Sorin Major Business
Table 100. Sorin Intracranial Drug Eluting Stents Product and Services
Table 101. Sorin Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Sorin Recent Developments/Updates
Table 103. TEDA Basic Information, Manufacturing Base and Competitors
Table 104. TEDA Major Business
Table 105. TEDA Intracranial Drug Eluting Stents Product and Services
Table 106. TEDA Intracranial Drug Eluting Stents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. TEDA Recent Developments/Updates
Table 108. Global Intracranial Drug Eluting Stents Sales Quantity by Manufacturer (2019-2024) & (Units)
Table 109. Global Intracranial Drug Eluting Stents Revenue by Manufacturer (2019-2024) & (USD Million)
Table 110. Global Intracranial Drug Eluting Stents Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 111. Market Position of Manufacturers in Intracranial Drug Eluting Stents, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 112. Head Office and Intracranial Drug Eluting Stents Production Site of Key Manufacturer
Table 113. Intracranial Drug Eluting Stents Market: Company Product Type Footprint
Table 114. Intracranial Drug Eluting Stents Market: Company Product Application Footprint
Table 115. Intracranial Drug Eluting Stents New Market Entrants and Barriers to Market Entry
Table 116. Intracranial Drug Eluting Stents Mergers, Acquisition, Agreements, and Collaborations
Table 117. Global Intracranial Drug Eluting Stents Sales Quantity by Region (2019-2024) & (Units)
Table 118. Global Intracranial Drug Eluting Stents Sales Quantity by Region (2025-2030) & (Units)
Table 119. Global Intracranial Drug Eluting Stents Consumption Value by Region (2019-2024) & (USD Million)
Table 120. Global Intracranial Drug Eluting Stents Consumption Value by Region (2025-2030) & (USD Million)
Table 121. Global Intracranial Drug Eluting Stents Average Price by Region (2019-2024) & (US$/Unit)
Table 122. Global Intracranial Drug Eluting Stents Average Price by Region (2025-2030) & (US$/Unit)
Table 123. Global Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2024) & (Units)
Table 124. Global Intracranial Drug Eluting Stents Sales Quantity by Type (2025-2030) & (Units)
Table 125. Global Intracranial Drug Eluting Stents Consumption Value by Type (2019-2024) & (USD Million)
Table 126. Global Intracranial Drug Eluting Stents Consumption Value by Type (2025-2030) & (USD Million)
Table 127. Global Intracranial Drug Eluting Stents Average Price by Type (2019-2024) & (US$/Unit)
Table 128. Global Intracranial Drug Eluting Stents Average Price by Type (2025-2030) & (US$/Unit)
Table 129. Global Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2024) & (Units)
Table 130. Global Intracranial Drug Eluting Stents Sales Quantity by Application (2025-2030) & (Units)
Table 131. Global Intracranial Drug Eluting Stents Consumption Value by Application (2019-2024) & (USD Million)
Table 132. Global Intracranial Drug Eluting Stents Consumption Value by Application (2025-2030) & (USD Million)
Table 133. Global Intracranial Drug Eluting Stents Average Price by Application (2019-2024) & (US$/Unit)
Table 134. Global Intracranial Drug Eluting Stents Average Price by Application (2025-2030) & (US$/Unit)
Table 135. North America Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2024) & (Units)
Table 136. North America Intracranial Drug Eluting Stents Sales Quantity by Type (2025-2030) & (Units)
Table 137. North America Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2024) & (Units)
Table 138. North America Intracranial Drug Eluting Stents Sales Quantity by Application (2025-2030) & (Units)
Table 139. North America Intracranial Drug Eluting Stents Sales Quantity by Country (2019-2024) & (Units)
Table 140. North America Intracranial Drug Eluting Stents Sales Quantity by Country (2025-2030) & (Units)
Table 141. North America Intracranial Drug Eluting Stents Consumption Value by Country (2019-2024) & (USD Million)
Table 142. North America Intracranial Drug Eluting Stents Consumption Value by Country (2025-2030) & (USD Million)
Table 143. Europe Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2024) & (Units)
Table 144. Europe Intracranial Drug Eluting Stents Sales Quantity by Type (2025-2030) & (Units)
Table 145. Europe Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2024) & (Units)
Table 146. Europe Intracranial Drug Eluting Stents Sales Quantity by Application (2025-2030) & (Units)
Table 147. Europe Intracranial Drug Eluting Stents Sales Quantity by Country (2019-2024) & (Units)
Table 148. Europe Intracranial Drug Eluting Stents Sales Quantity by Country (2025-2030) & (Units)
Table 149. Europe Intracranial Drug Eluting Stents Consumption Value by Country (2019-2024) & (USD Million)
Table 150. Europe Intracranial Drug Eluting Stents Consumption Value by Country (2025-2030) & (USD Million)
Table 151. Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2024) & (Units)
Table 152. Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity by Type (2025-2030) & (Units)
Table 153. Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2024) & (Units)
Table 154. Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity by Application (2025-2030) & (Units)
Table 155. Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity by Region (2019-2024) & (Units)
Table 156. Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity by Region (2025-2030) & (Units)
Table 157. Asia-Pacific Intracranial Drug Eluting Stents Consumption Value by Region (2019-2024) & (USD Million)
Table 158. Asia-Pacific Intracranial Drug Eluting Stents Consumption Value by Region (2025-2030) & (USD Million)
Table 159. South America Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2024) & (Units)
Table 160. South America Intracranial Drug Eluting Stents Sales Quantity by Type (2025-2030) & (Units)
Table 161. South America Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2024) & (Units)
Table 162. South America Intracranial Drug Eluting Stents Sales Quantity by Application (2025-2030) & (Units)
Table 163. South America Intracranial Drug Eluting Stents Sales Quantity by Country (2019-2024) & (Units)
Table 164. South America Intracranial Drug Eluting Stents Sales Quantity by Country (2025-2030) & (Units)
Table 165. South America Intracranial Drug Eluting Stents Consumption Value by Country (2019-2024) & (USD Million)
Table 166. South America Intracranial Drug Eluting Stents Consumption Value by Country (2025-2030) & (USD Million)
Table 167. Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity by Type (2019-2024) & (Units)
Table 168. Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity by Type (2025-2030) & (Units)
Table 169. Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity by Application (2019-2024) & (Units)
Table 170. Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity by Application (2025-2030) & (Units)
Table 171. Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity by Region (2019-2024) & (Units)
Table 172. Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity by Region (2025-2030) & (Units)
Table 173. Middle East & Africa Intracranial Drug Eluting Stents Consumption Value by Region (2019-2024) & (USD Million)
Table 174. Middle East & Africa Intracranial Drug Eluting Stents Consumption Value by Region (2025-2030) & (USD Million)
Table 175. Intracranial Drug Eluting Stents Raw Material
Table 176. Key Manufacturers of Intracranial Drug Eluting Stents Raw Materials
Table 177. Intracranial Drug Eluting Stents Typical Distributors
Table 178. Intracranial Drug Eluting Stents Typical Customers
List of Figures
Figure 1. Intracranial Drug Eluting Stents Picture
Figure 2. Global Intracranial Drug Eluting Stents Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Intracranial Drug Eluting Stents Consumption Value Market Share by Type in 2023
Figure 4. Cobalt-chromium Alloy Stents Examples
Figure 5. Magnesium Alloy Stents Examples
Figure 6. Stainless Steel Stents Examples
Figure 7. Others Examples
Figure 8. Global Intracranial Drug Eluting Stents Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Intracranial Drug Eluting Stents Consumption Value Market Share by Application in 2023
Figure 10. Hospital Examples
Figure 11. Specialty Clinic Examples
Figure 12. Others Examples
Figure 13. Global Intracranial Drug Eluting Stents Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Intracranial Drug Eluting Stents Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Intracranial Drug Eluting Stents Sales Quantity (2019-2030) & (Units)
Figure 16. Global Intracranial Drug Eluting Stents Average Price (2019-2030) & (US$/Unit)
Figure 17. Global Intracranial Drug Eluting Stents Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Intracranial Drug Eluting Stents Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Intracranial Drug Eluting Stents by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Intracranial Drug Eluting Stents Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Intracranial Drug Eluting Stents Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Intracranial Drug Eluting Stents Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Intracranial Drug Eluting Stents Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Intracranial Drug Eluting Stents Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Intracranial Drug Eluting Stents Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Intracranial Drug Eluting Stents Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Intracranial Drug Eluting Stents Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Intracranial Drug Eluting Stents Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Intracranial Drug Eluting Stents Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Intracranial Drug Eluting Stents Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Intracranial Drug Eluting Stents Average Price by Type (2019-2030) & (US$/Unit)
Figure 32. Global Intracranial Drug Eluting Stents Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Intracranial Drug Eluting Stents Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Intracranial Drug Eluting Stents Average Price by Application (2019-2030) & (US$/Unit)
Figure 35. North America Intracranial Drug Eluting Stents Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Intracranial Drug Eluting Stents Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Intracranial Drug Eluting Stents Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Intracranial Drug Eluting Stents Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Intracranial Drug Eluting Stents Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Intracranial Drug Eluting Stents Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Intracranial Drug Eluting Stents Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Intracranial Drug Eluting Stents Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Intracranial Drug Eluting Stents Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Intracranial Drug Eluting Stents Consumption Value Market Share by Region (2019-2030)
Figure 55. China Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Intracranial Drug Eluting Stents Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Intracranial Drug Eluting Stents Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Intracranial Drug Eluting Stents Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Intracranial Drug Eluting Stents Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Intracranial Drug Eluting Stents Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Intracranial Drug Eluting Stents Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Intracranial Drug Eluting Stents Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Intracranial Drug Eluting Stents Market Drivers
Figure 76. Intracranial Drug Eluting Stents Market Restraints
Figure 77. Intracranial Drug Eluting Stents Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Intracranial Drug Eluting Stents in 2023
Figure 80. Manufacturing Process Analysis of Intracranial Drug Eluting Stents
Figure 81. Intracranial Drug Eluting Stents Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Abbott
Medtronic Vascular
Advantec Vascular
B.Braun Melsengen
Boston Scientific
Terumo Medical
Biosensors
Biotronik
Blue Medical
DISA Vascular
Essen
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
TEDA
jiaGou

Add To Cart

gouMai

Buy Now